What makes Horizant® (gabapentin enacarbil) different? See what makes Horizant® unique 1 Horizant® is not the same medication as other gabapentin products Horizant® should not be used in place of other gabapentin products
Prescribing Information | Horizant® (gabapentin enacarbil) References: Horizant [package insert] Woburn, MA: Azurity Pharmaceuticals, Inc ; 2022 ; Food and Drug Administration Orange Book: approved drug products with therapeutic equivalence evaluations [gabapentin enacarbil]
For RLS (Restless Legs Syndrome) and PHN (Postherpetic Neuralgia) HORIZANT® (gabapentin enacarbil) Extended-Release Tablets are indicated for the treatment of moderate-to-severe primary Restless Legs Syndrome (RLS) in adults HORIZANT is not recommended for patients who are required to sleep during the daytime and remain awake at night HORIZANT® (gabapentin enacarbil) Extended-Release Tablets are indicated for the management of postherpetic neuralgia (PHN
Horizant® (gabapentin enacarbil) for RLS Treatment Horizant® (gabapentin enacarbil) Extended-Release Tablets are used to treat adults with moderate to severe primary Restless Legs Syndrome (RLS) See Important Safety Information
Savings | Horizant® (gabapentin enacarbil) Horizant® Copay Savings Card Patient: Eligible commercially insured patients may receive their first prescription of Horizant® 600 mg or 300 mg for as little as $0 (up to 60 tablets per month) For questions regarding your eligibility or benefits or if you wish to discontinue your participation, call 1-855-700-2990 (8 ᴀᴍ–8 ᴘᴍ ET, Monday–Friday)
Restless Legs Syndrome (RLS) | Horizant® (gabapentin enacarbil) Horizant® is the only FDA-approved alpha-2-delta ligand for treatment of moderate-to-severe Restless Legs (RLS) in adults 1,2 Learn more about how Horizant® relieved the symptoms of RLS patients in a clinical trial
Resources Savings | Horizant® (gabapentin enacarbil Horizant® Copay Savings Card Patient: Eligible commercially insured patients may receive their first prescription of Horizant® 600 mg or 300 mg for as little as $0 For questions regarding your eligibility or benefits or if you wish to discontinue your participation, call 1-855-700-2990 (8 ᴀᴍ–8 ᴘᴍ ET, Monday–Friday)
Pharmacokinetics | Horizant® (gabapentin enacarbil) The conventional gabapentin absorption pathway may become saturated, limiting the amount of drug that reaches systemic circulation 3; Horizant® is a PROdrug recognized by high-capacity nutrient transporters located through the intestinal tract 3; Horizant®’s absorption pathway does not become saturated at clinically relevant doses, enabling a greater proportion of the dose of drug to reach